Water Part1

Information about Water Part1

Published on November 7, 2007

Author: Gabriel

Source: authorstream.com

Content

Slide1:  Water for Pharmaceutical Use Part 1: Introduction and treatment Supplementary Training Modules on Good Manufacturing Practice WHO Technical Report Series No 929, 2005. Annex 3 Slide2:  Objective Water system requirements Water quality specifications Application of specific water to processes and dosage forms Water purification methods Storage and distribution systems Commissioning, qualification, operation and maintenance Water for Pharmaceutical Use Slide3:  Introduction Information on Water for Pharmaceutical Use (WPU) Quality of water for APIs, finished products, etc. GMP for design, installation, operation of systems Supplementary to general GMP guidelines See also other guidelines, pharmacopoeia, etc. Water for Pharmaceutical Use 1.1 Slide4:  Additional guidelines WHO Guideline for Drinking water quality (WHO) Water and steam systems (ISPE) Bioprocessing Equipment Standard (ASME – BPE 2000) European Pharmacopoeia, United States Pharmacopeia, International Pharmacopoeia Inspection of Utilities (PIC/S) Water for Pharmaceutical Use 1.3 Slide5:  Principles Like any starting material, production of water should conform to Good Manufacturing Practice (GMP) norms Potential for microbial growth Systems must be properly validated / qualified Water for parenteral use should not be contaminated with pyrogens or endotoxins Specifications and periodic testing are required Water for Pharmaceutical Use Slide6:  Why purify raw water? Although reasonably pure, it is always variable due to seasonal variations, regional variation in water quality Must remove impurities and control microbes to avoid contaminating products Treatment depends on water’s chemistry and contaminants, influenced by, e.g. rainfall, erosion, pollution, dissolution, sedimentation, decomposition Water for Pharmaceutical Use Slide7:  Contaminants of water (1) There is no pure water in nature, as it can contain up to 90 possible unacceptable contaminants Contaminant groups: Inorganic compounds Organic compounds Solids Gases Microorganisms Water for Pharmaceutical Use Slide8:  Contaminants of water (2) Problem minerals Calcium, magnesium, copper, aluminium, heavy metals, arsenic, lead, cadmium, nitrates Iron, manganese, silicates, carbon dioxide Hydrogen sulfide Phosphates Water for Pharmaceutical Use Slide9:  Contaminants of water (3) Microorganisms – Biofilm formation Protozoa Cryptosporidium Giardia Bacteria Pseudomonas Gram negative, non-fermenting bacteria Escherichia coli and coliforms Water for Pharmaceutical Use Slide10:  Biofilm formation Free-swimming aquatic bacteria use polymucosaccharides to colonize surfaces Complex communities evolve which shed microcolonies and bacteria Water for Pharmaceutical Use Slide11:  Background to water requirements and use Water is the most widely used substance / raw material Used in production, processing, formulation, cleaning, quality control Unique chemical properties Able to dissolve, absorb, adsorb, suspend compounds and contaminants Different grades of water quality available See also EMEA "Note for guidance on the quality of water for pharmaceutical use" Water for Pharmaceutical Use 1.2 Slide12:  Background to water requirements and use (2) Control quality of water Production Storage and distribution Contaminants, microbial and chemical quality Microbial contamination risk and concern Water is used on demand not subjected to testing and batch or lot release before use, therefore has to meet specification "on demand" when used Micro test results require incubation periods Water for Pharmaceutical Use 1.2 Slide13:  Water system requirements Design, installation, commissioning, qualification / validation, operation, performance and maintenance to ensure reliable, consistent production of water of required quality Operate within design capacity Prevent unacceptable microbial, chemical and physical contamination during production, storage and distribution Quality Assurance involved in approval of use after installation and maintenance work Water for Pharmaceutical Use 2. Slide14:  Water system requirements (2) Monitoring of water sources regularly Chemical and microbiological Endotoxin level where relevant Monitoring of system performance, storage and distribution systems Records of results, and action taken Validated sanitization procedure followed on a routine basis Water for Pharmaceutical Use 2. Slide15:  Water quality specifications Here address water in bulk (not for patient administration) Specifications in pharmacopoeia – relevant to national or international recommendations. Types of water include: Drinking water / potable water Purified water (PW) Highly Purified Water (HPW) Water for Injection (WFI) Water for Pharmaceutical Use 3. Slide16:  Drinking water / potable water Must comply with specification (WHO, ISO and national or regional agencies) – regular testing needed Supplied under continuous positive pressure Defect free plumbing system to prevent contamination Could be from public water supply system or natural sources Source water quality influences the treatment required Water for Pharmaceutical Use 3.2. Water for Pharmaceutical Use:  Drinking water: Natural sources could include springs, wells, rivers and lakes Treatment includes softening, ion removal, particle reduction, antimicrobial treatment 3.2 Water for Pharmaceutical Use Slide18:  Purified Water (PW) Prepared from potable water source Meet pharmacopoeia specification for chemical and microbial purity Protected from recontamination Protected from microbial proliferation Water for Pharmaceutical Use 3.3. Slide19:  Highly Purified Water (HPW) Prepared from potable water source Specification only in the European Pharmacopoeia Same quality standard as WFI including limit for endotoxins, but treatment method considered less reliable than distillation Prepared by combination of methods including reverse osmosis (RO), ultrafiltration (UF) and deionization (DI) Water for Pharmaceutical Use 3.4. Slide20:  Water for Injections (WFI) Prepared from potable water source WFI is not sterile WFI is not a final dosage form WFI is an intermediate bulk product According to The International and European Pharmacopoeias – final purification step should be distillation Water for Pharmaceutical Use 3.5 Slide21:  Application of specific water to processes and dosage forms Water used for different stages of: Washing, preparation, synthesis, production, formulation, control Which grade of water is suitable for a particular stage? Consider nature and intended use of intermediate or finished product, and stage at which water is used Let's look at types of water and indicate their use Water for Pharmaceutical Use 4. Slide22:  Complete the table Water for Pharmaceutical Use Slide23:  Water purification methods Manufacturer to select appropriate method of purification Appropriate sequence of purification steps Influenced by, e.g. Water quality specification Yield (efficiency) of the system Feed water quality Reliability and robustness of treatment system Supplier support, maintenance and operation costs Water for Pharmaceutical Use 5.1 Slide24:  Water purification system considerations Leaching from contact materials Adsorption Hygienic and sanitary design Corrosion resistance Leakage Proliferation of microbiological organisms Water for Pharmaceutical Use 5.1 Slide25:  Water purification system considerations (2) Tolerance to cleaning and sanitizing agents Capacity and output capability Instruments, sensors, controls, sampling points Space needed for installation and structural loading of premises Access needed for maintenance Regeneration and sanitization Water for Pharmaceutical Use 5.1 Slide26:  Pre-treatment steps Primary filtration and multimedia filter Coagulation or flocculation Desalination Softening Water for Pharmaceutical Use Slide27:  Water for Pharmaceutical Use Water for Pharmaceutical Use:  Water pre-treatment complex in a pre-treatment room Water for Pharmaceutical Use Slide29:  brine and salt tank brine drain by pass valve Water Softener – schematic drawing Water for Pharmaceutical Use Slide30:  Chlorine removal (Activated-carbon (AC) filtration or bisulphite) AC removes chlorine but bacteria can then grow AC filtration can remove organic impurities Bisulphite leaves sulphate residues but is antimicrobial Water for Pharmaceutical Use Slide31:  Production of drinking water Derived from raw water (e.g. well, river, reservoir) Processes may include: Filtration, softening Disinfection or sanitization Iron (ferrous) removal Precipitation Inorganic / organic reduction Water for Pharmaceutical Use 5.2 Slide32:  Production of drinking water (2) When done "in-house" – steps used and system configuration documented, and water quality routinely monitored Change control in case of changes to system Storage of water: no degradation, ensure turnover, routine testing "indirect impact system" – qualification not needed Water for Pharmaceutical Use 5.2 Slide33:  Production of drinking water (3) System permits draining and sanitization Storage tanks: Closed, with protected vents Allows visual inspection, draining and sanitization Care to prevent and control microbiological contamination of sand filters, carbon beds, water softeners Back-flushing, chemical or thermal sanitization and frequent regeneration, continuous waterflow Water for Pharmaceutical Use 5.2 Slide34:  Production of drinking water (4) Drinking water supplied by tanker – associated problems and risks Required vendor assessment Authorized certification activities Acceptability of delivery vehicle As receiving any other starting material Water for Pharmaceutical Use 5.2 Slide35:  Water treatment purification stages downstream of the pre-treatment system may include: Filtration Disinfection Reverse osmosis (RO) or deionization (DI) Distillation or ultrafiltration Water for Pharmaceutical Use Slide36:  Water for Pharmaceutical Use Slide37:  Reverse osmosis (RO) theory Water for Pharmaceutical Use Slide38:  Water for Pharmaceutical Use Slide39:  Use of reverse osmosis Advantages Disadvantages Many uses purified water feeding of distillation units or ultrafiltration units Water for Final Rinse Water for Injections (if permissible) Water for Pharmaceutical Use Slide40:  Production of Purified Water (PW) Use appropriate, qualified methods for production Factors to consider: Feed water quality and required water quality specification Sequence of purification stages needed Energy consumption, extent of pre-treatment needed Yield and efficiency of unit treatment steps Location and design of sampling points Appropriate instrumentation for measurements Water for Pharmaceutical Use 5.3 Slide41:  Production of Purified Water (2) Measurements: Flow Pressures Temperature Conductivity pH Total organic carbon (TOC), etc. Appropriately controlled, monitored, records maintained Water for Pharmaceutical Use 5.3 Slide42:  Production of Purified Water (3) Ambient temperature PW systems are susceptible to microbiological contamination – especially when static and periods of low or no demand Controls may include: Maintain flow at all times Control temperature in the system ( <25 degrees Celsius) UV disinfection Water treatment components that can be thermally sanitized Chemical sanitization (e.g. with ozone) Water for Pharmaceutical Use 5.3 Slide43:  Production of Highly Purified Water (HPW) Use appropriate, qualified methods for production Appropriate sequence of techniques As for PW Processes may include: Ion exchange Ultrafiltration Reverse Osmosis Water for Pharmaceutical Use 5.4 Slide44:  Production of Water for Injections (WFI) Pharmacopoeia requires distillation as preferred technique for final purification step Factors to consider: Feed water quality Required water quality specification Optimum generator sizing (prevent frequent start/stop) Blow-down and dump functions Cool-down venting (avoid contamination ingress) Water for Pharmaceutical Use 5.5

Related presentations


Other presentations created by Gabriel

The Four Seasons
05. 11. 2007
0 views

The Four Seasons

Old age is a gift
03. 10. 2007
0 views

Old age is a gift

ilcol
26. 11. 2007
0 views

ilcol

halloween 5
05. 11. 2007
0 views

halloween 5

Wright TES2007
05. 11. 2007
0 views

Wright TES2007

lpg training
06. 11. 2007
0 views

lpg training

cybercrime
13. 11. 2007
0 views

cybercrime

DS 2 NIAPS Technical
15. 11. 2007
0 views

DS 2 NIAPS Technical

Tropical Rainforest
20. 11. 2007
0 views

Tropical Rainforest

pb8 intro
21. 11. 2007
0 views

pb8 intro

PSTN
26. 11. 2007
0 views

PSTN

Tree ID
04. 01. 2008
0 views

Tree ID

D2 Khaku Aunali
02. 01. 2008
0 views

D2 Khaku Aunali

LibraryEdResources
19. 11. 2007
0 views

LibraryEdResources

Turkey 3
23. 11. 2007
0 views

Turkey 3

390
27. 09. 2007
0 views

390

AGE OF ANXIETY
27. 02. 2008
0 views

AGE OF ANXIETY

Legal Update
28. 02. 2008
0 views

Legal Update

REAP
28. 11. 2007
0 views

REAP

05 Tema2
01. 10. 2007
0 views

05 Tema2

andre isabelle
11. 03. 2008
0 views

andre isabelle

C01 Introduction
18. 03. 2008
0 views

C01 Introduction

2008ColquhounInvasiv ePlants
27. 03. 2008
0 views

2008ColquhounInvasiv ePlants

ahonen 1007
30. 03. 2008
0 views

ahonen 1007

haycock05
28. 09. 2007
0 views

haycock05

Dinesh Nair
28. 12. 2007
0 views

Dinesh Nair

barbara szymoniuk
16. 11. 2007
0 views

barbara szymoniuk

BearingPoint
29. 10. 2007
0 views

BearingPoint

060619 1515 Marler Replacement
04. 10. 2007
0 views

060619 1515 Marler Replacement

Leaving Home
28. 12. 2007
0 views

Leaving Home

astro moons
09. 10. 2007
0 views

astro moons